Are you Dr. Lau?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 37 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215Phone+1 617-667-6000
Summary
- Dr. Frank Lau, MD is a board certified plastic surgeon in Boston, Massachusetts. He is currently licensed to practice medicine in Massachusetts, Oregon, and Texas. He is affiliated with Touro Infirmary and Ochsner Medical Center.
Education & Training
Brigham and Women's Hospital/Harvard Medical SchoolResidency, Plastic Surgery - Integrated, 2006 - 2014
University of Michigan Medical SchoolClass of 2006
Certifications & Licensure
LA State Medical License 2014 - 2025
OR State Medical License 2023 - 2025
TX State Medical License 2018 - 2022
MA State Medical License 2009 - 2020- American Board of Plastic Surgery Plastic Surgery
Clinical Trials
- Limb Salvage Through Tissue Engineering: A Novel Treatment Modality Using Dehydrated Human Amnion/Chorion Membrane Start of enrollment: 2016 Feb 01
- A Prospective, Double-Blinded, Randomized Controlled Trial of dHACM for Incisional Hernia Prophylaxis Start of enrollment: 2020 May 20
- Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients Start of enrollment: 2021 May 21
Publications & Presentations
PubMed
- 48 citationsNational health disparities in incisional hernia repair outcomes: An analysis of the Healthcare Cost and Utilization Project National Inpatient Sample (HCUP-NIS) 2012-...Ryan D. Hoffman, Denise Danos, Frank H. Lau
Surgery. 2021-06-01 - 1826 citationsHighly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNALuigi Warren, Philip D. Manos, Tim Ahfeldt, Yuin-Han Loh, Hu Li
Cell Stem Cell. 2010-11-05 - 3 citationsExpression of the preadipocyte marker ZFP423 is dysregulated between well-differentiated and dedifferentiated liposarcoma.Thanh N Dang, Rafael P Tiongco, Loren M Brown, Jessica L Taylor, John M Lyons
BMC Cancer. 2022-03-21
Press Mentions
LSU Health Study Shows Promise of NB-UVB Phototherapy in Hospitalized COVID-19 PatientsJune 3rd, 2022- Lsu Health New Orleans Opens Clinical Trial Studying Liquid Aspirin for Early Covid-19February 13th, 2022
Alberta Researchers Part of Rush to Learn Vitamin D's Role in COVID-19 PreventionMay 22nd, 2020- Join now to see all
